AR Asset Management’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-73,700
| Closed | -$91K | – | 116 |
|
|
2025
Q1 | $91K | Hold |
73,700
| – | – | 0.02% | 113 |
|
|
2024
Q4 | $229K | Hold |
73,700
| – | – | 0.05% | 108 |
|
|
2024
Q3 | $208K | Buy |
73,700
+3,000
| +4% | +$8.47K | 0.05% | 112 |
|
|
2024
Q2 | $384K | Hold |
70,700
| – | – | 0.09% | 97 |
|
|
2024
Q1 | $304K | Hold |
70,700
| – | – | 0.07% | 101 |
|
|
2023
Q4 | $389K | Hold |
70,700
| – | – | 0.1% | 96 |
|
|
2023
Q3 | $321K | Buy |
70,700
+30,000
| +74% | +$136K | 0.09% | 97 |
|
|
2023
Q2 | $126K | Hold |
40,700
| – | – | 0.03% | 110 |
|
|
2023
Q1 | $29K | Buy |
+40,700
| New | +$29K | 0.01% | 112 |
|
|
2022
Q4 | – | Sell |
-27,900
| Closed | -$103K | – | 113 |
|
|
2022
Q3 | $103K | Hold |
27,900
| – | – | 0.03% | 115 |
|
|
2022
Q2 | $92K | Hold |
27,900
| – | – | 0.03% | 119 |
|
|
2022
Q1 | $123K | Buy |
27,900
+20,750
| +290% | +$91.5K | 0.03% | 117 |
|
|
2021
Q4 | $68K | Sell |
7,150
-20,750
| -74% | -$197K | 0.02% | 116 |
|
|
2021
Q3 | $472K | Sell |
27,900
-100
| -0.4% | -$1.69K | 0.13% | 97 |
|
|
2021
Q2 | $781K | Buy |
+28,000
| New | +$781K | 0.22% | 78 |
|